View all newsletters
Receive our newsletter - data, insights and analysis delivered to you
July 26, 2011

Dr Reddy’s Acquires Assets of JB Chemicals & Pharmaceuticals

Dr Reddy's Laboratories has entered into an agreement to acquire the pharmaceutical prescription portfolio of JB Chemicals & Pharmaceuticals in Russia and the Commonwealth of Independent States. The agreement involves acquisition of 20 brands, key ones being Metrogyl and Jocet, for

By cms admin

Dr Reddy’s Laboratories has entered into an agreement to acquire the pharmaceutical prescription portfolio of JB Chemicals & Pharmaceuticals in Russia and the Commonwealth of Independent States.

The agreement involves acquisition of 20 brands, key ones being Metrogyl and Jocet, for a consideration of $34.85m.

Dr Reddy’s has also entered into a supply agreement with JB Chemicals for the continued manufacture and supply of these products, including the acquired brands.

Dr Reddy’s Laboratories managing director and chief operating officer Satish Reddy said the acquisition will help expand the company’s prescription, hospital and over-the-counter portfolio.

Related Companies

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. A weekly roundup of the latest news and analysis, sent every Friday. The pharmaceutical industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU

Thank you for subscribing to Pharmaceutical Technology